The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 323.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 10.00 (3.125%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 323.00
SOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

17 Jul 2012 07:00

RNS Number : 8099H
Somero Enterprises Inc.
17 July 2012
 



PRESS ANNOUNCEMENT

17 July 2012

Somero Enterprises, Inc®

Trading Update

Somero Enterprises, Inc (the "Company") is pleased to announce that the strong trading experienced by the Company in the first quarter of 2012 has continued into the second quarter. Revenues for H1 2012 are now expected to be some 50% ahead of those reported in H1 2011. As a result of this increased sales volume, EBITDA achieved in H1 2012 is expected to be slightly ahead of the market's forecasts for the Group's entire full year performance.

 

North America showed strong growth in the first half, benefitting from mild weather conditions and a benign economic environment. Performance during this period from the Chinese business was also strong, reflecting the investment made by the Company in the region. Sales from the Company's new product the S-840 and the SXPD large line machines were significantly higher than in the same period last year. Whilst the Company still anticipates strong trading from these regions/products, it is likely that respective rates of growth are slower in the second half of the year consistent with previous years.

 

With healthy demand continuing, the Company is implementing plans to add some costs in new product development, training, marketing and sales initiatives to take full advantage of a stronger sales environment. This is intended to put Somero in the best position to deliver growth in the medium and longer term, as well as to sustain the shorter term recovery that is evident in 2012. At this stage, the Board expects that the increased costs will lead to second half profitability being lower than the first half, albeit that the outturn for the full year is still expected to be substantially ahead of current forecasts for 2012.

 

 

For further information, please contact:

Somero Enterprises, Inc

Jack Cooney, CEO

Mike Niemela, CFO

 

Tel: +1 239 210 6507

Canaccord Genuity Hawkpoint (Nominated Adviser)

Chris Robinson

Serge Rissi

 

Tel: +44 20 7665 4500

 

Canaccord Genuity Limited (Broker)

Piers Coombs

Seb Jones

Tel: +44 20 7523 8000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBKODQPBKKDOD
Date   Source Headline
30th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Mar 20246:06 pmRNSTransaction in Own Shares and Total Voting Rights
19th Mar 20243:07 pmRNSRestricted Stock Units& Director/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
7th Feb 20247:00 amRNSNotice of Investor Presentation
31st Jan 20247:00 amRNSTrading Update
5th Jan 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Jan 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Dec 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Dec 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Nov 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Nov 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Oct 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Oct 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Oct 20237:55 amRNSTransaction in Own Shares and Total Voting Rights
2nd Oct 20237:00 amRNSBoard Change
27th Sep 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Sep 20238:49 amRNSTransaction in Own Shares and Total Voting Rights
18th Sep 20237:00 amRNSDirector/PDMR Shareholding & Change of NOMAD name
13th Sep 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Aug 20237:00 amRNSInterim Results
29th Aug 20237:00 amRNSBoard Change
8th Aug 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Aug 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Jul 20237:00 amRNSNotice of Investor Presentation
24th Jul 20237:00 amRNSTrading Update
5th Jul 20234:52 pmRNSTransaction in Own Shares and Total Voting Rights
4th Jul 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Jun 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jun 20237:00 amRNSTrading Update
14th Jun 20233:46 pmRNSTransaction in Own Shares and Total Voting Rights
12th Jun 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
18th May 20233:10 pmRNSResult of AGM
17th May 20236:10 pmRNSTransaction in Own Shares and Total Voting Rights
17th May 20237:00 amRNSAGM Statement
12th May 20232:26 pmRNSTransaction in Own Shares and Total Voting Rights
4th May 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Apr 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Apr 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Apr 20236:15 pmRNSUpdate re: RSUs & Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.